ProfileGDS4890 / 209490_s_at
TitleSystemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
OrganismHomo sapiens


SLE 1 SLE 2 SLE 3 SLE 4 ND 55 ND 56 ND 57 systemic lupus erythematosus healthy not immunized before YFV immunization after YFV immunization before YFV immunization after YFV immunization before YFV immunization after YFV immunization GSM1256968 GSM1256969 GSM1256970 GSM1256971 GSM1256988 GSM1256991 GSM1256989 GSM1256992 GSM1256990 GSM1256993 33% 32% 38% 50% 57% 48% 18% 31% 23% 49% sort by individual sort by disease state sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1256968SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 16.5209533
GSM1256969SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 25.9741432
GSM1256970SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 38.718238
GSM1256971SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 415.329150
GSM1256988Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 55 before YFV22.733357
GSM1256991Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 55 seven days after YFV14.290748
GSM1256989Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 56 before YFV2.8180318
GSM1256992Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 56 seven days after YFV5.856531
GSM1256990Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 57 before YFV3.6193623
GSM1256993Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 57 seven days after YFV14.524449